Advertisements

More Blood Pressure Medication Recalls Due To Cancer Concerns

You may want an MBA. But you want to avoid NMBA.

NMBA stands for N-Methylnitrosobutyric acid, something that you don’t want in your blood pressure medications. But alas, this probable carcinogen continues to appear in various medications at higher than acceptable levels.

The latest news is that Torrent Pharmaceuticals Limited is further expanding its recall of Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, USP, according to the U.S. Food and Drug Administration (FDA). The FDA announcement includes five more lots of these medications. The additional lots add to the lots of blood pressure medications that have been recalled in the past 14 months or so.

In 2018 and 2019, it seems like news about potential cancer-causing contaminants in medications has become as repetitive as the lyrics “My Name Is” in Eminem’s song “My Name Is.” I’ve written about such news for blood pressure medications in November of last year, January of this year, and again March of this year. Then, just last week I covered impurities found in a common heartburn medication, ranitidine. Then, on Thursday, I added an update that Novartis was halting its distribution of ranitidine, the generic form of Zantac, until further testing could be done.

Today In: Innovation

As they say when you soil your pants, one time may be an accident but more than three times is a trend. It is time to take a closer look at how drugs are being manufactured, stored, and distributed and how such processes are being monitored. As I have mentioned before, making medications is not the same as making handbags. You don’t, at least you shouldn’t, eat your handbags. While a poorly-made handbag could lead to social embarrassment, a poorly-made medication can have much greater and even life-threatening implications.

The FDA is the main agency to protect you against fraudulent and contaminated medications. But the FDA currently may not have the funding and the resources to carefully check everything that every drug manufacturer and distributor is doing, especially when some of these operations are rapidly changing or occurring overseas.

For now, if you are taking blood pressure medications, or any medications for that matter, pay attention to FDA warnings and recall news. The FDA maintains a searchable listing of active product warnings and recalls. As a precautionary measure, you may want to search for a medication before starting it. You can also check with your pharmacist to make sure that your medication is not on a recall or warning list. Of course, if you do find that your medication has a warning or is being recalled, don’t just stop taking it. That can be like trying to return a parachute while you are using it. Check with your doctor first to determine your course of action.

Follow me on Twitter or LinkedIn. Check out my website.

I am a writer, journalist, professor, systems modeler, computational and digital health expert, avocado-eater, and entrepreneur, not always in that order. Currently, I am a Professor of Health Policy and Management at the City University of New York (CUNY), Executive Director of PHICOR (@PHICORteam), and Associate Professor at the Johns Hopkins Carey Business School. My previous positions include serving as Executive Director of the Global Obesity Prevention Center (GOPC) at Johns Hopkins University, Associate Professor of International Health at the Johns Hopkins Bloomberg School of Public Health, Associate Professor of Medicine and Biomedical Informatics at the University of Pittsburgh, and Senior Manager at Quintiles Transnational, working in biotechnology equity research at Montgomery Securities, and co-founding a biotechnology/bioinformatics company. My work involves developing computational approaches, models, and tools to help health and healthcare decision makers in all continents (except for Antarctica) and has been supported by a wide variety of sponsors such as the Bill and Melinda Gates Foundation, the NIH, AHRQ, CDC, UNICEF, USAID and the Global Fund. I have authored over 200 scientific publications and three books. Follow me on Twitter (@bruce_y_lee) but don’t ask me if I know martial arts.

Source: More Blood Pressure Medication Recalls Due To Cancer Concerns

121K subscribers
Dr. Luke Laffin, staff cardiologist in Preventive Cardiology and Clinical Specialist in Hypertension at Cleveland Clinic answers questions that patients often ask about taking high blood pressure medicines: types of medications, side effects, when to call the doctor, role of self-blood pressure monitoring (including how often), the best time to take blood pressure medications, and if there is a chance that patients can come off medications. He ends the program with three important points for patients with high blood pressure.

Advertisements

Heart Checks While You Shop: NHS Announces Plan To Have Pharmacies Check Shoppers’ Heart Health In Bid To Cut Deaths

Shoppers will be offered on-the-spot NHS heart checks to detect signs of killer conditions.

High street pharmacies will be overhauled under the national plan to prevent up to 150,000 heart attacks and strokes within a decade.

The country’s most senior doctor said the new approach would be a “game changer,” helping to identify risks far earlier, with advice on lifestyle overhauls as well as targeted medication.

Pilot schemes have seen some types of strokes fall by a quarter.

From October, chemists will begin rolling out the “rapid detection service,” which includes mobile electrocardiograms to spot irregular heartbeats, as well as checks on blood pressure and cholesterol levels.

If successful, the scheme will be rolled out to every pharmacist in the country within three years.

An NHS sign is pictured at St Thomas’ Hospital  Credit: AFP

The plans aim to identify those at risk far earlier, when treatment and lifestyle changes are most likely to be effective.

Pharmacists will be expected to dole out advice on exercise and diet, with results passed directly to GP practices, who can prescribe the right medication.

Professor Stephen Powis, NHS England medical director, said: “Heart disease and strokes dramatically cut short lives, and leave thousands of people disabled every year, so rapid detection of killer conditions through high street heart checks will be a game-changer.”

The plans, launched to coincide with the world’s biggest heart conference, follow proposals to scrap “one size fits all” health MOTs at GP surgeries.  In future, GPs will be expected to increasingly target checks on those thought to be at greatest risk, due to their medical and genetic history, while routine screening tests are offered by pharmacists.

Heart disease is Britain’s biggest killer, with deaths from heart attacks, strokes and circulatory diseases accounting for 160,000 deaths in the UK every year.

More than 7 million people are living with heart and circulatory diseases.

Speaking at the European Society for Cardiology (ESC) conference, in Paris, Professor Bryan Williams, author of its guidelines on disease prevention, said: “This is hugely important. Heart disease and stroke remain the most important cause of premature death and disability and we have the means to prevent the many of them.

“The key is early detection of those at risk and doing this is a way that is convenient for the public, not having to wait for a GP appointment that could be done simply the local pharmacy.”

Chemists will begin rolling out the “rapid detection service,” which includes mobile electrocardiograms to spot irregular heartbeats, as well as checks on blood pressure and cholesterol levels. Credit: Anthony Devlin/PA

Yesterday Dexter Canoy, clinical epidemiologist from the University of Oxford, presented research showing that raised blood pressure at the age of 40 is a clear indicator of the risk of suffering heart attacks and strokes in later life.

He said: “We need to find ways to target the people who aren’t seeing their GP regularly – the middle-aged men who think they are healthy, but haven’t actually been checked.”

“If opening it up to pharmacies and shopping malls means that people are more likely to have their blood pressure checked, that could make a significant difference,” he said, calling for proper evaluation of the measures.

The checks are part of a new £13 billion five year contract for community pharmacists which aims to expand their roles and offer earlier detection of diseases.

More than 100 pharmacies in Cheshire and Merseyside have begun offering blood pressures screening services, under a local initiative, backed by the British Heart Foundation, with plans to recruit more than 200 more chemists to the service as it expands.

Medics said widespread use of the monitors by pharmacies, hospitals and individual patients could cut costs, speed diagnosis and avoid preventable hospital admissions.

Pilot schemes in Lambeth and Southwark in south London identified more than 1,400 patients suffering from atrial fibrillation – an irregular heart rhythm –  who should have been taking blood thinning drugs, but were not. In total, 1,300 of the patients have now been put on the medication, leading to a 25 per cent reduction in the rate of strokes linked to their heart condition.

Keith Ridge, England’s chief pharmaceutical officer, said: “This new contract makes the most of the clinical skills of local pharmacists and establishes pharmacies across England as local health hubs – open in the evenings and at weekends – where people can go for an ever-increasing range of clinical health checks and treatment.”

Simon Gillespie, chief executive of the British Heart Foundation, said: “Millions of people in England are living with conditions such as high blood pressure which, if left untreated, significantly increase the risk of having a potentially deadly heart attack or stroke. Reaching more people and encouraging them to check their blood pressure, working with them to lower it where necessary, will play an absolutely critical role in saving lives in the coming years.”

By:

 

Source: Heart checks while you shop: NHS announces plan to have pharmacies check shoppers’ heart health in bid to cut deaths

Blood Pressure Medication Recall: What Is In This That May Cause Cancer – Bruce Y. Lee

1.jpg

Do you have an idea of what is in these blood pressure medications? Take away the “I” from an idea and you’ve got a NDEA. That’s the chemical that seems to have contaminated certain lots of a type of blood pressure medication. NDEA is short for N-nitrosodiethylamine. PubChem describes NDEA as a “synthetic light-sensitive, volatile, clear yellow oil that is soluble in water, lipids, and other organic solvents,” which is “used as gasoline and lubricant additive, antioxidant, and stabilizer for industry materials.”The description also mentions NDEA emitting “toxic fumes” when heated to a high enough temperature and being used in the lab to cause liver tumors for experiments……..

Read more: https://www.forbes.com/sites/brucelee/2018/11/02/blood-pressure-medication-recall-what-is-in-them-that-may-cause-cancer/#5a8c7831211e

 

 

 

 

Your kindly Donations would be so effective in order to fulfill our future research and endeavors – Thank you

%d bloggers like this:
Skip to toolbar